Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding AG    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about ROCHE HOLDING AG
01/15ROCHE HOLDINGS AG : Deutsche Bank gives a Neutral rating
MD
01/13ROCHE : Exane BNP Paribas Lowers Price Target on Roche, Maintains Outperform Rec..
MT
01/13ROCHE HOLDINGS AG : JP Morgan reiterates its Neutral rating
MD
01/13ROCHE : Unit Regeneron to Supply Additional Doses of COVID-19 Antibody Cocktail ..
MT
01/12ROCHE : confirms US government agreement to purchase additional doses of Regener..
AQ
01/12PRESS RELEASE : Roche confirms US government -2-
DJ
01/12PRESS RELEASE : Roche confirms US government agreement to purchase additional do..
DJ
01/12ROCHE : CHEPLAPHARM acquires the rights to Rivotril
AQ
01/12ROCHE HOLDINGS AG : Receives a Buy rating from UBS
MD
01/12ROCHE : Tecentriq-Avastin Treatment Improves Survival Rate in Liver Cancer Patie..
MT
01/12ROCHE : to present updated data confirming Tecentriq in combination with Avastin..
AQ
01/12PRESS RELEASE : Roche to present updated data -2-
DJ
01/12PRESS RELEASE : Roche to present updated data confirming Tecentriq in combinatio..
DJ
01/11ROCHE : Trial of COVID-19 blood plasma finds no benefit in severely ill patients
RE
01/11ROCHE : Trial of COVID-19 blood plasma finds no benefit in severely ill patients
RE
More most relevant news
All news about ROCHE HOLDING AG
01/15ROCHE HOLDINGS AG : Deutsche Bank gives a Neutral rating
MD
01/14Qiagen warns against using standard tests to track coronavirus variants
RE
01/13CHUGAI PHARMACEUTICAL : Conducts Digital Transformation in Manufacturing with IB..
AQ
01/13ROCHE : Exane BNP Paribas Lowers Price Target on Roche, Maintains Outperform Rec..
MT
01/13ROCHE HOLDINGS AG : JP Morgan reiterates its Neutral rating
MD
01/13ROCHE : Unit Regeneron to Supply Additional Doses of COVID-19 Antibody Cocktail ..
MT
01/12ROCHE : confirms US government agreement to purchase additional doses of Regener..
AQ
01/12PRESS RELEASE : Roche confirms US government -2-
DJ
01/12PRESS RELEASE : Roche confirms US government agreement to purchase additional do..
DJ
01/12ROCHE : CHEPLAPHARM acquires the rights to Rivotril
AQ
More news
News in other languages on ROCHE HOLDING AG
01/15Aktien Schweiz gehen moderat fester ins Wochenende
01/15ROCHE HOLDINGS AG : Deutsche Bank neutre sur le dossier
01/15Deutsche Bank startet Roche mit 'Hold' - Ziel 325 Franken
01/15AVIS D'ANALYSTES DU JOUR : Devoteam, Faurecia, Geberit, Gecina, Heineken, Novart..
01/13Partenariat entre Roche et Domosafety dans les maladies neuromusculaires
01/13ROCHE HOLDINGS AG : JP Morgan neutre sur le dossier
01/13JPMorgan belässt Roche auf 'Neutral' - Ziel 345 Franken
01/13REGENERON PHARMACEUTICALS : USA bestellen 1,25 Mio Dosen des Covid-19-Mittels vo..
01/13ROCHE : achat de doses du cocktail d'anticorps par Washington
01/13Roche-Partner Regeneron liefert an USA zusätzliche Dosen zur Covid-19-Behandl..
Analyst Recommendations on ROCHE HOLDING AG
01/15ROCHE HOLDINGS AG : Deutsche Bank gives a Neutral rating
MD
01/13ROCHE : Exane BNP Paribas Lowers Price Target on Roche, Maintains Outperform Rec..
MT
01/13ROCHE HOLDINGS AG : JP Morgan reiterates its Neutral rating
MD
01/12ROCHE HOLDINGS AG : Receives a Buy rating from UBS
MD
01/08ROCHE HOLDINGS AG : Morgan Stanley is less optimistic
MD
More recommendations
Press releases
01/13CHUGAI PHARMACEUTICAL : Conducts Digital Transformation in Manufacturing with IB..
AQ
01/12ROCHE : confirms US government agreement to purchase additional doses of Regener..
AQ
01/12ROCHE : CHEPLAPHARM acquires the rights to Rivotril
AQ
01/12ROCHE : to present updated data confirming Tecentriq in combination with Avastin..
AQ
01/11ROCHE : Xofluza approved by the European Commission for the treatment of influen..
AQ
More press releases